Breaking News, Financial News

3Q Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

3Q Revenues: $44.2 million (flat)

3Q Earnings: $1.4 million (-68%)

YTD Revenues: $133.2 million (-8%)

YTD Earnings: $2.9 million (-83%)

Comments: Total contract revenue for the quarter was $37.9 million, up 20%. Contract revenue for discovery services was $10.0 million, up 61%. Contract revenue from development and small scale manufacturing in the quarter was $9.6 million, up 45%. Large scale manufacturing revenues were $18.2 million, down 2%. Results for the quarter and YTD reflect a reduction in Allegra royalties, as well as the effects on large scale manufacturing due to the discontinuation of one product supplied to GE Healthcare in 2005.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters